Muhammad Baghdadi - Institute for Genetic Medicine - Academic lecturer

Muhammad Baghdadi

Institute for Genetic Medicine

Academic lecturer

Sapporo, Hokkaido | Japan

Additional Specialties: Cancer Immunology & Immunotherapy

ORCID logohttps://orcid.org/0000-0002-2347-8889

Muhammad Baghdadi - Institute for Genetic Medicine - Academic lecturer

Muhammad Baghdadi

Introduction

Primary Affiliation: Institute for Genetic Medicine - Sapporo, Hokkaido , Japan

Additional Specialties:

Metrics

Number of Publications

45

Publications

Number of Profile Views

130

Profile Views

Number of Article Reads

394

Reads

Number of Citations

183

Citations

Top co-authors

Haruka Wada
Haruka Wada

Virginia Polytechnic Institute and State University

13
Ken-Ichiro Seino
Ken-Ichiro Seino

Graduate School of Medicine

11
Masahisa Jinushi
Masahisa Jinushi

Institute for Genetic Medicine

8
Hironori Yoshiyama
Hironori Yoshiyama

Shimane University Faculty of Medicine

6
Hirotoshi Dosaka-Akita
Hirotoshi Dosaka-Akita

Hokkaido University School of Medicine

5
Ichiro Kinoshita
Ichiro Kinoshita

Hokkaido University School of Medicine

4
Hideo Yagita
Hideo Yagita

Juntendo University School of Medicine

4
Shigeki Chiba
Shigeki Chiba

Institute for Genetic Medicine

4
Hiraku Endo
Hiraku Endo

Institute for Genetic Medicine

4
Hirotake Abe
Hirotake Abe

Hokkaido University Graduate School of Medicine

3

Publications

45Publications

394Reads

183PubMed Central Citations

Interleukin-34, a comprehensive review.

J Leukoc Biol 2018 Nov 1;104(5):931-951. Epub 2018 Aug 1.

Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.

View Article
November 2018
4 Reads
4.289 Impact Factor

Enhanced expression of IL-34 in an inflammatory cyst of the submandibular gland: a case report.

Inflamm Regen 2018 10;38:12. Epub 2018 Jul 10.

1Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Kita-Ku, Kita-15 Nishi-7, Sapporo, 060-0815 Japan.

View Article
July 2018
9 Reads

Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma.

Inflamm Regen 2018 5;38. Epub 2018 Mar 5.

1Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Kita-15 Nishi-7, Sapporo, 060-0815 Japan.

View Article
March 2018
6 Reads

High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers.

Sci Rep 2018 01 11;8(1):418. Epub 2018 Jan 11.

Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Kita-15 Nishi-7, Sapporo, 060-0815, Japan.

View Article
January 2018
14 Reads
5.078 Impact Factor

Interleukin 34, from pathogenesis to clinical applications.

Cytokine 2017 11 5;99:139-147. Epub 2017 Sep 5.

Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Japan. Electronic address:

View Article
November 2017
26 Reads
2.664 Impact Factor

Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cells.

Proc Natl Acad Sci U S A 2016 06 25;113(24):E3394-402. Epub 2016 May 25.

Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Kita-15 Nishi-7, Sapporo 060-0815, Japan;

View Article
June 2016
38 Reads
9.809 Impact Factor

Identification of a highly immunogenic mouse breast cancer sub cell line, 4T1-S.

Hum Cell 2016 Apr 8;29(2):58-66. Epub 2016 Feb 8.

Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Kita-15 Nishi-7, Sapporo, 060-0815, Japan.

View Article
April 2016
12 Reads

Induction of macrophage-like immunosuppressive cells from mouse ES cells that contribute to prolong allogeneic graft survival.

PLoS One 2014 30;9(10):e111826. Epub 2014 Oct 30.

Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.

View Article
December 2015
18 Reads
3.234 Impact Factor

New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.

Transplantation 2015 Nov;99(11):2301-10

1 Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan. 2 Department of Renal and Genitourinary Surgery, Graduate school of medicine, Hokkaido University, Sapporo, Japan.

View Article
November 2015
99 Reads
3.828 Impact Factor

Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity.

Cancer Immunol Immunother 2015 Aug 24;64(8):941-9. Epub 2015 Apr 24.

Institute for Genetic Medicine, Hokkaido University, Kita15 Nishi7, Sapporo, Hokkaido, 060-0815, Japan.

View Article
August 2015
36 Reads
5 Citations
3.941 Impact Factor

Blocking monoclonal antibodies of TIM proteins as orchestrators of anti-tumor immune response.

MAbs 2014 30;6(5):1124-32. Epub 2014 Oct 30.

a Division of Immunobiology; Institute for Genetic Medicine ; Hokkaido University ; Sapporo , Japan.

View Article
August 2015
5 Reads
1 Citation
4.558 Impact Factor

Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells.

Cancer Res 2014 May 17;74(10):2698-709. Epub 2014 Mar 17.

Authors' Affiliations: Research Center for Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University; Department of Medical Oncology, Hokkaido University Graduate School of Medicine, Sapporo; and Center for AIDS research, Kumamoto University, Kumamoto, Japan

View Article
May 2014
7 Reads
9.329 Impact Factor

The impact of the TIM gene family on tumor immunity and immunosuppression.

Cell Mol Immunol 2014 Jan 16;11(1):41-8. Epub 2013 Dec 16.

Research Center for Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, Hokkaido, Japan.

View Article
January 2014
5 Reads
4.112 Impact Factor

TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance.

Immunity 2013 Dec 5;39(6):1070-81. Epub 2013 Dec 5.

Research Center for Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, Sapporo, 060-0815, Japan. Electronic address:

View Article
December 2013
12 Reads
21.561 Impact Factor

Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas.

Cancer Immunol Immunother 2013 Apr 10;62(4):629-37. Epub 2012 Nov 10.

Research Center for Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-0815, Japan.

View Article
April 2013
9 Reads
3.941 Impact Factor

MFG-E8 regulates the immunogenic potential of dendritic cells primed with necrotic cell-mediated inflammatory signals.

PLoS One 2012 25;7(6):e39607. Epub 2012 Jun 25.

Research Center for Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.

View Article
March 2013
14 Reads
3 Citations
3.234 Impact Factor

Regulation of cancer stem cell activities by tumor-associated macrophages.

Am J Cancer Res 2012 20;2(5):529-39. Epub 2012 Aug 20.

Research Center for Infection-associated cancer, Institute for Genetic Medicine, Hokkaido University Sapporo, Japan.

View Article
October 2012
5 Reads
3.968 Impact Factor

ATM-mediated DNA damage signals mediate immune escape through integrin-αvβ3-dependent mechanisms.

Cancer Res 2012 Jan 17;72(1):56-65. Epub 2011 Nov 17.

Research Center for Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, Tokyo, Japan.

View Article
January 2012
4 Reads
6 Citations
9.329 Impact Factor

Top co-authors

Haruka Wada
Haruka Wada

Virginia Polytechnic Institute and State University

13
Ken-Ichiro Seino
Ken-Ichiro Seino

Graduate School of Medicine

11
Masahisa Jinushi
Masahisa Jinushi

Institute for Genetic Medicine

8
Hironori Yoshiyama
Hironori Yoshiyama

Shimane University Faculty of Medicine

6
Hirotoshi Dosaka-Akita
Hirotoshi Dosaka-Akita

Hokkaido University School of Medicine

5
Ichiro Kinoshita
Ichiro Kinoshita

Hokkaido University School of Medicine

4
Hideo Yagita
Hideo Yagita

Juntendo University School of Medicine

4
Shigeki Chiba
Shigeki Chiba

Institute for Genetic Medicine

4
Hiraku Endo
Hiraku Endo

Institute for Genetic Medicine

4
Hirotake Abe
Hirotake Abe

Hokkaido University Graduate School of Medicine

3